Stanford University has announced an upcoming clinical trial that investigates the efficacy of immersive technology-based audio biofeedback for pain management. This innovative behavioral intervention, comparing its effects against a control group receiving no intervention, aims to offer groundbreaking insights into pain relief methods.
Scheduled to begin recruitment, the trial is expected to pave the way for medical device advancements and practical applications in the field of behavioral therapy. Clinical, quality, and regulatory teams should stay informed about developments as they unfold.
Study Details: What Is Being Tested?
The trial sponsored by Stanford University focuses on two interventions for pain: an immersive technology-based audio biofeedback approach and a control group without any such intervention. The immersive system uses non-visual feedback to potentially modify pain perception behaviorally.
Both groups will be closely monitored for safety, performance, and outcomes. Physicians, researchers, and regulatory teams will assess the effectiveness against established benchmarks. Recruitment for participants has not yet begun, according to ClinicalTrials.gov.
Why This Trial Matters
Behavioral therapies are gaining attention in pain management. Leveraging non-visual auditory biofeedback could revolutionize the field, introducing lower-risk options with significant therapeutic potential.
For clinical teams and regulatory authorities, this study could provide evidence-based data on the interplay of technology, human behavior, and chronic pain treatments. Understanding this connection may help streamline regulatory pathways for future medical device clearances addressing pain.
Next Steps and Expectations
The trial’s early announcement allows industry players to observe potential methodologies and outcomes for immersive audio technology in clinical settings. Professionals should watch for regulatory filings as trials progress and final results are published.
Stanford University’s proactive approach could set a precedent for other institutions exploring non-invasive alternatives to traditional pain management strategies.
FAQ
- What is the purpose of this trial?
The trial aims to compare an immersive audio biofeedback intervention to no intervention for its effect on pain management. - Who is conducting the study?
Stanford University is the primary sponsor of this research effort. - When will recruitment begin?
The trial is listed as “Not yet recruiting,” with no specific start date provided. - Why is this study important?
It explores a novel, technology-driven method for managing pain, potentially offering safer and more accessible solutions.
Conclusion
This upcoming trial explores how immersive audio biofeedback can transform pain management methods. With rigorous monitoring and scientific evaluation, the results of this study could shape future treatments and regulatory standards.
Disclaimer
This article is intended for informational purposes only. It is not legal advice. Regulatory and clinical teams should refer to official sources for guidance.
Full Announcement
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07227142?term=medical+device